RESULTS OF A MULTICENTER CLINICAL TRIAL TO EVALUATE THE PREFERENTIAL HYPERACUITY PERIMETER FOR DETECTION OF AGE-RELATED MACULAR DEGENERATION
Author:
- PREFERENTIAL HYPERACUITY PERIMETER (PHP) RESEARCH GROUPPGPREFERENTIAL HYPERACUITY PERIMETER (PHP) RESEARCH GROUP
- 1 April 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Retina
- Vol. 25 (3) , 296-303
Abstract
To compare the preferential hyperacuity perimeter (PHP) with an Amsler grid in detection of age-related macular degeneration (AMD). Patients underwent refraction, visual acuity examination, PHP, Amsler grid examination, and macular photography. One hundred fifty patients participated in the trial. Of 19 eyes with neovascular AMD, 19 (100%) were positive on the PHP, and 10 (53%), on the Amsler grid. Of 27 eyes with geographic atrophy, 26 (96%) were positive on the PHP, and 12 (44%), on the Amsler grid. Of 20 eyes with intermediate AMD, 14 (70%) were positive on the PHP, and 4 (20%), on the Amsler grid. Of 51 eyes with early AMD, 21 (41%) were positive on the PHP, and 4 (8%), on the Amsler grid. Of 33 eyes with no AMD, 6 (18%) were positive on the PHP, and none, on the Amsler grid. Thus, 80 (68%) of 117 patients with AMD had a positive PHP, while 30 (26%) had positive results of Amsler grid examination (P < 0.001, McNemar test). The PHP had greater sensitivity, although with a relatively high rate of false-positive results for healthy individuals, than the Amsler grid in detecting AMD-related lesions.Keywords
This publication has 25 references indexed in Scilit:
- Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1American Journal of Ophthalmology, 2003
- A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision LossArchives of Ophthalmology (1950), 2001
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2American Journal of Ophthalmology, 2001
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinArchives of Ophthalmology (1950), 1999
- Preventative OphthalmologyOphthalmology, 1995
- Laser Photocoagulation for Juxtafoveal Choroidal NeovascularizationArchives of Ophthalmology (1950), 1994
- Prevalence of Age-related MaculopathyOphthalmology, 1992
- Argon Laser Photocoagulation for Neovascular MaculopathyArchives of Ophthalmology (1950), 1991
- The Dimensions of the Problem of Eye Disease Among the ElderlyOphthalmology, 1987
- Age-Related Macular Degeneration and Blindness due to Neovascular MaculopathyArchives of Ophthalmology (1950), 1984